Actinium Pharmaceuticals, Inc (ATNM) Stock Price

1.11 ▲ +0.03 (+2.78%)
Open: 1.07 Vol: 97.92K Day's range: 1.06 - 1.11 Apr 13, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ATNM Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY NEUTRAL NEUTRAL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 1.09▲ 1.08▲ 1.08▲ 1.13▼ 1.06▲
MA10 1.09▲ 1.08▲ 1.08▲ 1.07▲ 1.10▲
MA20 1.08▲ 1.09▲ 1.10▼ 1.08▲ 1.24▼
MA50 1.08▲ 1.13▼ 1.10▲ 1.12▼ 1.43▼
MA100 1.12▼ 1.08▲ 1.08▲ 1.27▼ 2.13▼
MA200 1.11▼ 1.10▼ 1.11▼ 1.42▼ 4.91▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.004▲ 0.003▲ -0.002▼ 0.012▲ -0.004▼
RSI 68.414▲ 50.638▲ 49.474▼ 50.757▲ 42.496▼
STOCH 100.000▲ 55.556     44.048     68.389     27.172    
WILL %R 0.000▲ 0.000▲ -46.154     -41.045     -64.645    
CCI 135.484▲ 117.512▲ 47.447     26.703     -55.751    
Latest Filters Detected On ATNM
RSI $ATNM RSI(14) Crossed Above 50 Set Alert
MA $ATNM Price Crossed Above MA(26) Set Alert
MA $ATNM Price Crossed Above MA(7) Set Alert
Actinium Pharmaceuticals, Inc News
Actinium Pharmaceuticals, Inc.: Actinium Pharmaceuticals Announces New Pan-Tumor Preclinical Data for ATNM-400 in Solid Tumors and Differentiated Mechanism for Actimab-A in AML ...
Tuesday, April 07, 2026 01:29 AM
New data underscoring the potential of ATNM-400 as a first-in-class Ac-225 radioconjugate with broad pan-tumor efficacy across multiple solid tumor models Actimab-A ...
Actinium Pharmaceuticals Announces New Pan-Tumor Preclinical Data for ATNM-400 in Solid Tumors and Differentiated Mechanism for Actimab-A in AML to be Presented at 2026 AACR ...
Monday, April 06, 2026 05:44 AM
Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today announced the publication of two abstracts that will be ...
U.S.: NYSE American
Friday, March 20, 2026 04:46 PM
Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel targeted therapies. It also develops and markets medicines for relapsed or ...
ATNM historical stock data
date open high low close volume
13/04/26 1.07 1.11 1.06 1.11 97,917
10/04/26 1.15 1.15 1.08 1.08 74,346
09/04/26 1.17 1.175 1.105 1.14 88,642
08/04/26 1.17 1.22 1.1694 1.17 128,700
07/04/26 1.10 1.19 1.09 1.17 184,484
06/04/26 1.01 1.18 1.01 1.09 345,611
02/04/26 0.99 1.0082 0.9803 0.9804 57,889
01/04/26 0.98 1.01 0.9717 0.99 126,649
31/03/26 0.99 1.03 0.952 0.9953 171,374
30/03/26 1.02 1.03 0.99 0.99 160,922
Quote Details
52wk Low:0.952
52wk High:1.94
Vol:97.92K
Avg Vol(3m):2M
1Y Chng:-22.92%
1M Chng:-2.63%
Add to Watch List
More Information
Index NYSE AMEX Composite
Market Cap. 33.88M